Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > MC Options

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Dec 04, 2023 6:02pm

124 Views

Post# 35767967

RE:RE:RE:RE:RE:RE:RE:RE:MC Options

Well thanks again for adding so much to this board and I admitted having a different name on another board as I did not know you are supposed to have the same moniker. A rule I.did not know. Well did u find out yet if u r allowed to exercise the options rather than calling everyone out for providing relevant information. You better get a hold of kirk and let him know your findings.
Funny how people hate to get corrected and own up to it and apologize as it is so much easier to not man up and sling trash as this speaks to one's real self.

<< Previous

Bullboard Posts

Next >>

Cybeats expands to Belgium with Capyx commercial partnership